# Esketamine Versus Sufentanil for Sedation in Patients Undergoing ERCP

> **NCT07702240** · NA · NOT_YET_RECRUITING · sponsor: **Ren Da** · enrollment: 530 (estimated)

## Conditions studied

- Biliary Tract Diseases
- Procedural Sedation and Analgesia

## Interventions

- **DRUG:** Esketamine
- **DRUG:** Sufentanil

## Key facts

- **NCT ID:** NCT07702240
- **Lead sponsor:** Ren Da
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-10
- **Primary completion:** 2028-03-10
- **Final completion:** 2028-03-10
- **Target enrollment:** 530 (ESTIMATED)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07702240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07702240, "Esketamine Versus Sufentanil for Sedation in Patients Undergoing ERCP". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07702240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*